Search

Your search keyword '"Vousden, Karen H."' showing total 808 results

Search Constraints

Start Over You searched for: Author "Vousden, Karen H." Remove constraint Author: "Vousden, Karen H."
808 results on '"Vousden, Karen H."'

Search Results

2. Mixed responses to targeted therapy driven by chromosomal instability through p53 dysfunction and genome doubling

3. The role of APOBEC3B in lung tumor evolution and targeted cancer therapy resistance

6. A century of the Warburg effect

7. Embracing cancer complexity: Hallmarks of systemic disease

8. Apoptotic cell death in disease—Current understanding of the NCCD 2023

10. ALDH1L2 regulation of formate, formyl-methionine, and ROS controls cancer cell migration and metastasis

13. Regulation of ROS signaling by TIGAR induces cancer-modulating responses in the tumor microenvironment.

14. Obesity, white adipose tissue and cancer.

18. PHGDH is required for germinal center formation and is a therapeutic target in MYC-driven lymphoma

21. Serine synthesis pathway inhibition cooperates with dietary serine and glycine limitation for cancer therapy

25. PHGDH is required for germinal center formation and is a therapeutic target in MYC- driven lymphoma

32. Molecular mechanisms of cell death: recommendations of the Nomenclature Committee on Cell Death 2018

33. Canagliflozin impairs T cell effector function via metabolic suppression in autoimmunity

39. Apoptotic cell death in disease—Current understanding of the NCCD 2023

40. Figure S7 from Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer

41. Data from Oncogenic KRAS Induces NIX-Mediated Mitophagy to Promote Pancreatic Cancer

42. Supplementary Figures 1-8 from Inhibitors of Ubiquitin-Activating Enzyme (E1), a New Class of Potential Cancer Therapeutics

45. Canagliflozin impairs T cell effector function via metabolic suppression in autoimmunity

Catalog

Books, media, physical & digital resources